VEGF-VEGFR2 inhibitor-associated hyaline occlusive glomerular microangiopathy: a Japanese single-center experience

Clinicopathological features and outcomes of diabetic kidney disease with extracapillary hypercellularity: a Japanese single-center experience

(2020) Ayano Saito et al.   Clinical and Experimental Nephrology

Predictive factors for the development of proteinuria in cancer patients treated with bevacizumab, ramucirumab, and aflibercept: a single-institution retrospective analysis

(2020) Yuko Kanbayashi et al.   Scientific Reports

Onconephrology: The intersections between the kidney and cancer

(2020) Mitchell H. Rosner et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The risk of nephrotic syndrome with non-VEGF inhibitory antineoplastic drugs: from viewpoint of the adverse event reports in Japan

(2020) Kouji Okada et al.   Clinical and Experimental Nephrology

Thrombotic Microangiopathy and Acute Kidney Injury Induced After Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors VEGF Blockade-Related TMA After Intravitreal Use

(2020) Ramy M. Hanna et al.   Frontiers in Medicine

Therapeutic Inhibition of VEGF Signaling and Associated Nephrotoxicities

(2019) Chelsea C. Estrada et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Renal-limited thrombotic microangiopathy after switching from bevacizumab to ramucirumab: a case report

(2019) Ryo Yamada et al.   BMC Nephrology

Nephrotic syndrome associated with ramucirumab therapy

(2019) Teruhiro Fujii et al.   MEDICINE

Characteristic morphological changes in anti-VEGF therapy induced glomerular microangiopathy

(2018) Frederick Pfister et al.   HISTOPATHOLOGY

Bevacizumab-associated glomerular microangiopathy

(2018) Fermin Person et al.   MODERN PATHOLOGY

Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience

(2016) Masatoyo Ozawa et al.   Clinical and Experimental Nephrology

Onco-nephrology: current concepts and future perspectives

(2015) Y. Kitai et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Proteinuria in Patients with Solid Tumors Treated with Ramucirumab: A Systematic Review and Meta-Analysis

(2015) Omar Abdel-Rahman et al.   CHEMOTHERAPY

Kidney Diseases Associated With Anti-Vascular Endothelial Growth Factor (VEGF)

(2014) Hassan Izzedine et al.   MEDICINE

Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy

(2013) Hassan Izzedine et al.   KIDNEY INTERNATIONAL

All anti-vascular endothelial growth factor drugs can induce 'pre-eclampsia-like syndrome': a RARe study

(2013) C. Vigneau et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Pros and cons for C4d as a biomarker

(2012) Danielle Cohen et al.   KIDNEY INTERNATIONAL

Bevacizumab Increases Risk for Severe Proteinuria in Cancer Patients

(2010) S. Wu et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Glomerular Structure and Function Require Paracrine, Not Autocrine, VEGF-VEGFR-2 Signaling

(2010) K. Sison et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

VEGF Inhibition and Renal Thrombotic Microangiopathy

(2008) Vera Eremina et al.   NEW ENGLAND JOURNAL OF MEDICINE